Published in Rev Endocr Metab Disord on March 01, 2016
Diabetes and the Small Intestine. Curr Treat Options Gastroenterol (2017) 0.75
Medical devices for the treatment of obesity. Nat Rev Gastroenterol Hepatol (2017) 0.75
Central nervous system control of food intake. Nature (2000) 15.85
Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial. JAMA (2014) 2.19
Sensory transmission in the gastrointestinal tract. Neurogastroenterol Motil (2007) 1.71
Cooperation between brain and islet in glucose homeostasis and diabetes. Nature (2013) 1.59
Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. Surgery (2008) 1.51
Treatment of Patients with Obese Type 2 Diabetes with Tantalus-DIAMOND® Gastric Electrical Stimulation: Normal Triglycerides Predict Durable Effects for at Least 3 Years. Horm Metab Res (2015) 1.51
The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity. Obes Surg (2012) 1.30
Methods of gastric electrical stimulation and pacing: a review of their benefits and mechanisms of action in gastroparesis and obesity. Neurogastroenterol Motil (2009) 1.22
Are gastrointestinal symptoms related to diabetes mellitus and glycemic control? Eur J Gastroenterol Hepatol (2008) 1.03
Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial. Surg Obes Relat Dis (2008) 1.00
Nutrient-sensing mechanisms in the gut as therapeutic targets for diabetes. Diabetes (2013) 0.97
Brain regulation of energy balance and body weight. Rev Endocr Metab Disord (2013) 0.96
Fasting plasma triglycerides predict the glycaemic response to treatment of type 2 diabetes by gastric electrical stimulation. A novel lipotoxicity paradigm. Diabet Med (2013) 0.96
Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial. J Obes (2015) 0.95
Gut fat sensing in the negative feedback control of energy balance--recent advances. Physiol Behav (2011) 0.94
Gastric stimulation for weight loss. World J Gastroenterol (2012) 0.91
Implantable gastric stimulation for the treatment of severe obesity. Obes Surg (2004) 0.91
Peripheral mechanisms in appetite regulation. Gastroenterology (2014) 0.90
The hypothalamic arcuate nucleus and the control of peripheral substrates. Best Pract Res Clin Endocrinol Metab (2014) 0.88
Electrical stimulation as treatment for obesity and diabetes. J Diabetes Sci Technol (2007) 0.88
The gut-brain axis in obesity. Best Pract Res Clin Gastroenterol (2014) 0.82
abiliti Closed-Loop Gastric Electrical Stimulation System for Treatment of Obesity: Clinical Results with a 27-Month Follow-Up. Obes Surg (2015) 0.80
Molecular development of the extrinsic sensory innervation of the gastrointestinal tract. Auton Neurosci (2010) 0.80
Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-Year Results of the VBLOC DM2 Study. Obes Surg (2016) 0.79
Gastric electrical stimulation treatment of type 2 diabetes: effects of implantation versus meal-mediated stimulation. A randomized blinded cross-over trial. Physiol Rep (2015) 0.79
Early experience with customized, meal-triggered gastric electrical stimulation in obese patients. Obes Surg (2015) 0.79
A pilot study to compare meal-triggered gastric electrical stimulation and insulin treatment in Chinese obese type 2 diabetes. Diabetes Technol Ther (2015) 0.77
Long-term outcomes of gastric electrical stimulation in children with gastroparesis. J Pediatr Surg (2015) 0.77